Different Effects of Iron Indices on Mortality in Patients With Autosomal Dominant Polycystic Kidney Disease After Long-Term Hemodialysis: A Nationwide Population-Based Study-Reference-Cited by-同舟云学术

Different Effects of Iron Indices on Mortality in Patients With Autosomal Dominant Polycystic Kidney Disease After Long-Term Hemodialysis: A Nationwide Population-Based Study

Published:2019-09 Issue:5 Volume:29 Page:444-453
ISSN:1051-2276
Container-title:Journal of Renal Nutrition
language:en
Short-container-title:Journal of Renal Nutrition

Author:

Yeh Shu-Ching,Lin Yi-Chun,Hong Ying-Chung,Hsu Chih-Cheng,Lin Yen-Chung,Wu Mai-Szu^ORCID

Publisher

Elsevier BV

Subject

Nephrology,Nutrition and Dietetics,Medicine (miscellaneous)

Reference24 articles.

1. Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines;Hung;Nephrology (Carlton),2014

2. ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target;Hung;Kidney Int,2014

3. KDOQI Clinical practice guidelines and Clinical practice recommendations for anemia in chronic kidney disease;Am J Kidney Dis,2006

4. KDOQI US commentary on the 2012 KDIGO Clinical practice guideline for anemia in CKD;Kliger;Am J Kidney Dis,2013

5. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease;Tsubakihara;Ther Apher Dial,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the relationship between erythropoiesis-stimulating agents and mortality in hemodialysis patients: A systematic review and meta-analysis;PLOS ONE;2023-11-09

2. Taiwan renal data report system: Framework, function, and development;Nephrology;2023-08-07

3. Association between Iron Status and Survival in Patients on Chronic Hemodialysis;Nutrients;2023-05-31

4. How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome;European Journal of Medical Research;2023-01-09

5. Hydrogen Sulfide as a Potential Future Therapy for Chronic Kidney Disease, Hyperhomocysteinemia, and Management of Polycystic Kidney Disease;Hydrogen Sulfide in Kidney Diseases;2023